Sarah C. Armstrong, MD
Director, Duke Healthy Lifestyles Program
Department / Division
Pediatrics /
Pediatrics-Primary Care
Address
4020 North Roxboro Street
Durham, NC 27704
Appointment Telephone
919-620-5356
Office Telephone
919-620-5356
Fax Telephone
919-471-6930
- MD, University of Virginia School of Medicine, 2000
- Pediatrics, Children's Hospital of Philadelphia (Pennsylvania), 2003
Clinical Interests
Comprehensive treatment of childhood obesity
Research Interests
Dr. Armstrong's clinical and research interests are in the prevention and treatment of childhood and adolescent obesity. As director of the Duke Children's Healthy Lifestyles Program, Dr. Armstrong oversees a cohort of over 3000 overweight children and teenagers. Research questions of particular interest include sustaining effective outpatient managment of overweight and obese children in a primary care setting, and factors that determine level of reimbursement.
This physician (or a member of their immediate family) has a working relationship (i.e. consulting, research, and/or educational services) with the companies listed below. These relations have been reported to the health system leadership and, when appropriate, management plans are in place to address potential conflicts.
- Active Biotech
- Amgen, Inc.
- Analysis Group Inc.
- Bristol-Myers Squibb
- CR Bard, Inc.
- Decision Resources, Inc.
- Dendreon Corporation
- Easton Associates
- Gerson Lehrman Group, Inc.
- GlaxoSmithKline
- Guidepoint Clinical
- Imclone Systems Incorporated
- Johnson & Johnson
- Kohl's Corporation
- Leerink Swann and Company
- Medivation, Inc.
- Pfizer Inc.
- Sanofi-Aventis
- UBM Medical
- Wyeth (Pfizer)
Representative Publications
2009 Armstrong S, Bravender T, Bailey M, Russell A, Chung R. Beyond Diet and Exercise: Alternative Therapies for Childhood Obesity. Parts 1 and 2, Review of Endocrinology. 2000.
(2009)
Armstrong S. Multimodal Childhood Obesity Treatment: an Evidence Based Review. Review of Endocrinology. 2008.
(2008)
